HF
EVLVW

HRT Financial’s Evolv Technologies Warrant EVLVW Stock Holding History

HRT Financial’s Portfolio EVLVW Stock Details EVLVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-26,198
Closed -$9K – 3134
2022
Q1 		$9K Sell
26,198
-27,244
-51% -$13.4K ﹤0.01% 2907
2021
Q4 		$42K Sell
53,442
-6,666
-11% -$7.86K ﹤0.01% 2864
2021
Q3 		$85K Buy
+60,108
New +$86.9K ﹤0.01% 2941

Other funds holding EVLVW

UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial's EVLVW Position: Q2 2022 in Review

HRT Financial sold out of Evolv Technologies Warrant (EVLVW) in Q2 2022, closing a stake of 26,198 shares — an estimated $9K sold.

HRT Financial first reported a position in EVLVW in Q3 2021 and held it in 3 quarters. The position peaked at $85K in Q3 2021. 15 funds tracked by Wall St. Rank hold EVLVW as of Q2 2022.

  • HRT Financial reported no remaining Evolv Technologies Warrant position as of Q2 2022 after selling out during the quarter.
  • HRT Financial sold 26,198 Evolv Technologies Warrant shares in Q2 2022, an estimated $9K.
  • HRT Financial first reported a position in Evolv Technologies Warrant in Q3 2021 and held it in 3 quarters.
  • HRT Financial's Evolv Technologies Warrant position peaked at $85K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Evolv Technologies Warrant as of Q2 2022.

Based on HRT Financial's 13F filing for Q2 2022, filed 12 Aug 2022.